Tzvi Palash

2013

In 2013, Tzvi Palash earned a total compensation of $604.7K as Chief Operating Officer at Protalix BioTherapeutics, a 10% decrease compared to previous year.

Compensation breakdown

Bonus$20,000
Option Awards$72,055
Salary$231,668
Stock Awards$208,822
Other$72,105
Total$604,650

Palash received $231.7K in salary, accounting for 38% of the total pay in 2013.

Palash also received $20K in bonus, $72.1K in option awards, $208.8K in stock awards and $72.1K in other compensation.

Rankings

In 2013, Tzvi Palash's compensation ranked 8,691st out of 12,286 executives tracked by ExecPay. In other words, Palash earned more than 29.3% of executives.

ClassificationRankingPercentile
All
8,691
out of 12,286
29th
Division
Manufacturing
3,158
out of 4,612
32nd
Major group
Chemicals And Allied Products
1,003
out of 1,466
32nd
Industry group
Drugs
763
out of 1,160
34th
Industry
Biological Products, Except Diagnostic Substances
126
out of 200
37th
Source: SEC filing on July 1, 2016.

Palash's colleagues

We found four more compensation records of executives who worked with Tzvi Palash at Protalix BioTherapeutics in 2013.

2013

David Aviezer

Protalix BioTherapeutics

Chief Executive Officer

2013

Yoseph Shaaltiel

Protalix BioTherapeutics

Executive Vice President, Research and Development

2013

Yossi Maimon

Protalix BioTherapeutics

Chief Financial Officer

2013

Einat Almon

Protalix BioTherapeutics

Senior Vice President, Product Development

You may also like